Publications by authors named "Stephanie Plent"

Claim this Profile
T
Trends in P2Y12 Inhibitor Use in Patients Referred for Invasive Evaluation of Coronary Artery Disease in Contemporary US Practice.
Weihong Fan, Stephanie Plent, Jayne Prats, Efthymios N Deliargyris

Am J Cardiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of anticoagulants and outcomes in STEMI patients undergoing PPCI in the US hospitals: Bivalirudin, heparin plus GPI or heparin alone?
Stephanie Plent, Michael Mitchell, Weihong Fan, Robert Werner

Hosp Pract (1995)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost implications of intraprocedural thrombotic events during PCI.
Stephanie Plent, Weihong Fan, Ajay Kirtane, Sorin J Brener, Philippe Genereux

Catheter Cardiovasc Interv· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of acute ST-segment elevation myocardial infarction.
Matthias Schwenkglenks, Toby J Toward, Stephanie Plent, Thomas D Szucs, Daniel J Blackman

Heart· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of switching to bivalirudin for a primary percutaneous coronary intervention in a US hospital.
Natalia Olchanski, Katherine A Slawsky, Stephanie Plent, Carla Kado, Philip L Cyr

Hosp Pract (1995)· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis